-
Sector Analysis
Non-Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Non-Small Cell Lung Cancer (NSCLC) is any type of epithelial lung cancer other than small cell lung cancer (SCLC). The most common types of NSCLC are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma, but there are several other types that occur less frequently, and all types can occur in unusual histologic variants. Although NSCLCs are associated with cigarette smoke, adenocarcinomas may be found in patients who have never smoked. The non-small cell lung cancer marketed and pipeline drugs market...
-
Sector Analysis
EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) – Epidemiology Forecast to 2025
Lung cancer is a disease of uncontrolled cell growth in the lung tissues. It is one of the most commonly occurring cancers in the world (IARC, 2016). Lung cancer is classified into three main types: non-small cell lung cancer (NSCLC), small cell lung cancer, and lung carcinoid tumor. NSCLC is the most common type of lung cancer, making up about 85% of all lung cancers. Small cell lung cancer accounts for 10-15% of lung cancers, while carcinoid tumors are the...
-
Product Insights
Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016" provides an overview of Recurrent Malignant Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on Recurrent Malignant Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Synovial Sarcoma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Synovial Sarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Synovial Sarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Synovial Sarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Thymic Carcinoma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Thymic Carcinoma Global Clinical Trials Review, H2, 2016" provides an overview of Thymic Carcinoma clinical trials scenario. This report provides top line data relating to the clinical trials on Thymic Carcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Medullary Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Medullary Thyroid Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Salivary Gland Cancer Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Salivary Gland Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Salivary Gland Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Salivary Gland Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Bile Duct Cancer (Cholangiocarcinoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Bone Metastasis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H2, 2016" provides an overview of Bone Metastasis clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Metastasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016" provides an overview of Muscle Invasive Bladder Cancer (MIBC) clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Invasive Bladder Cancer (MIBC). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.